IMMUNITYBIO, INC. Marketable Securities
IMMUNITYBIO, INC. (IBRX) had Marketable Securities of $300.00 thousand as of 2024-12-31, per its 10-K filed 2025-03-03.
Financial Statements › Balance Sheet › Assets
us-gaap:MarketableSecurities · last filed 2025-03-03
- 2024-12-31: Marketable Securities $300.00K.
- 2024-09-30: Marketable Securities $400.00K.
- 2024-06-30: Marketable Securities $900.00K.
- 2024-03-31: Marketable Securities $1.60M.
| Period end | Marketable Securities |
|---|---|
| 2024-12-31 | $300.00K 10-K · filed 2025-03-03 |
| 2024-09-30 | $400.00K 10-Q · filed 2024-11-12 |
| 2024-06-30 | $900.00K 10-Q · filed 2024-08-12 |
| 2024-03-31 | $1.60M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $900.00K 10-K · filed 2025-03-03 |
| 2023-09-30 | $1.70M 10-Q · filed 2023-11-09 |
| 2022-12-31 | $2.50M 10-K · filed 2024-03-19 |
| 2014-12-31 | $0.00 10-K · filed 2017-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 |